RASSF1 and neoplasm: Furthermore, it was also observed that three TSGs are frequently inactivated by methylation: RASSF1A (55%), RAR-β2 (70%), and MGMT (34%) can also be identified in the circulating tumor DNA of CM patients, which makes them useful diagnostic and prognostic biomarkers in the clinical setting [88,89].